Methadone Hydrochloride — products, DINs, and Canadian availability
This page lists Health Canada–registered pharmaceutical products whose active ingredient list includes Methadone Hydrochloride. We track 39 distinct Drug Identification Numbers (DINs) for this molecule, of which 20 are currently in marketed status. Across those registrations there are 14 manufacturers or marketing authorization holders, 3 dosage forms, and 4 distinct strength presentations.
Procurement teams normally arrive here for one of three reasons: a specific brand is unavailable and an equivalent registration is needed; a clinical protocol requires a comparator containing Methadone Hydrochloride in a defined strength; or a pharmacy needs to know which manufacturers still hold an active Canadian registration before committing to a substitution. The table below answers the first question directly. For the second and third, Nexara Health can confirm live availability, remaining shelf life, and landed cost from Canadian stock or from any of more than 40 regulated international source markets.
Registration status is not the same as availability. A product can hold marketed status in the Drug Product Database and still be on allocation, discontinued by the holder, or unavailable in the pack size a hospital needs. Where a Methadone Hydrochloride product is in shortage, our Canadian drug shortage tracker carries the reported status, the reason where the manufacturer has published one, and the marketed alternatives sharing the same active ingredient.
Dosage forms and strengths recorded for Methadone Hydrochloride
Dosage forms: Tablet, Solution, Drops. Strengths: 5 MG, 10 MG, 25 MG, 1 MG.
Manufacturers and marketing authorization holders
APOTEX INC, EUROVET ANIMAL HEALTH B.V., BAUSCH HEALTH, CANADA INC., HOECHST CANADA INC., HOECHST ROUSSEL CANADA INC., VALEO PHARMA INC, JAMP PHARMA CORPORATION, KNIGHT THERAPEUTICS INC., PALADIN PHARMA INC., STERINOVA INC., MALLINCKRODT CANADA ULC, ODAN LABORATORIESLTD, ENDO OPERATIONS LTD., PHARMASCIENCE INC.
Registered products containing Methadone Hydrochloride
| DIN | Product | Manufacturer | Strength | Dosage form | Status |
|---|---|---|---|---|---|
| 02533650 | APO-METHADONE | APOTEX INC | 5 MG | Tablet | Marketed |
| 02533669 | APO-METHADONE | APOTEX INC | 10 MG | Tablet | Marketed |
| 02533677 | APO-METHADONE | APOTEX INC | 25 MG | Tablet | Marketed |
| 02533642 | APO-METHADONE | APOTEX INC | 1 MG | Tablet | Marketed |
| 02496658 | COMFORTAN | EUROVET ANIMAL HEALTH B.V. | 10 MG | Solution | Marketed |
| 02224577 | COPHYLAC | BAUSCH HEALTH, CANADA INC. | 10 MG | Drops | Dormant |
| 00116343 | COPHYLAC | HOECHST CANADA INC. | 10 MG | Drops | Cancelled Post Market |
| 01987577 | COPHYLAC DROPS | HOECHST ROUSSEL CANADA INC. | 10 MG | Drops | Cancelled Post Market |
| 00116351 | COPHYLAC EXPECTORANT | HOECHST CANADA INC. | 10 MG | Drops | Cancelled Post Market |
| 02224585 | COPHYLAC EXPECTORANT DROPS | VALEO PHARMA INC | 10 MG | Drops | Cancelled Post Market |
| 01987801 | COPHYLAC EXPECTORANT DROPS | HOECHST ROUSSEL CANADA INC. | 10 MG | Drops | Cancelled Post Market |
| 02495783 | JAMP METHADONE ORAL CONCENTRATE | JAMP PHARMA CORPORATION | 10 MG | Solution | Marketed |
| 02247699 | METADOL | KNIGHT THERAPEUTICS INC. | 5 MG | Tablet | Marketed |
| 02247698 | METADOL | KNIGHT THERAPEUTICS INC. | 1 MG | Tablet | Marketed |
| 02247700 | METADOL | KNIGHT THERAPEUTICS INC. | 10 MG | Tablet | Marketed |
| 02241377 | METADOL | KNIGHT THERAPEUTICS INC. | 10 MG | Solution | Marketed |
| 02247694 | METADOL | KNIGHT THERAPEUTICS INC. | 1 MG | Solution | Marketed |
| 02247701 | METADOL | KNIGHT THERAPEUTICS INC. | 25 MG | Tablet | Marketed |
| 02247374 | METADOL-D | KNIGHT THERAPEUTICS INC. | 1 MG | Solution | Marketed |
| 02247693 | METADOL-D | PALADIN PHARMA INC. | 1 MG | Tablet | Cancelled Pre Market |
| 02247697 | METADOL-D | PALADIN PHARMA INC. | 25 MG | Tablet | Cancelled Pre Market |
| 02247696 | METADOL-D | PALADIN PHARMA INC. | 10 MG | Tablet | Cancelled Pre Market |
| 02247695 | METADOL-D | PALADIN PHARMA INC. | 5 MG | Tablet | Cancelled Pre Market |
| 02244290 | METADOL-D | KNIGHT THERAPEUTICS INC. | 10 MG | Solution | Marketed |
| 02481979 | METHADONE HYDROCHLORIDE ORAL CONCENTRATE USP | STERINOVA INC. | 10 MG | Solution | Approved |
| 02394596 | METHADOSE | MALLINCKRODT CANADA ULC | 10 MG | Solution | Marketed |
| 02394618 | METHADOSE | MALLINCKRODT CANADA ULC | 10 MG | Solution | Marketed |
| 02495880 | ODAN-METHADONE | ODAN LABORATORIESLTD | 10 MG | Solution | Marketed |
| 02495872 | ODAN-METHADONE | ODAN LABORATORIESLTD | 10 MG | Solution | Marketed |
| 02388391 | PMS-METHADONE | ENDO OPERATIONS LTD. | 5 MG | Tablet | Cancelled Pre Market |
| 02388405 | PMS-METHADONE | ENDO OPERATIONS LTD. | 10 MG | Tablet | Cancelled Pre Market |
| 02388383 | PMS-METHADONE | ENDO OPERATIONS LTD. | 1 MG | Tablet | Cancelled Pre Market |
| 02388413 | PMS-METHADONE | ENDO OPERATIONS LTD. | 25 MG | Tablet | Cancelled Pre Market |
| 02552728 | PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE | PHARMASCIENCE INC | 10 MG | Solution | Marketed |
| 02552736 | PMS-METHADONE HYDROCHLORIDE ORAL CONCENTRATE | PHARMASCIENCE INC | 10 MG | Solution | Marketed |
| 02572052 | PMS-METHADONE TABLETS | PHARMASCIENCE INC | 1 MG | Tablet | Approved |
| 02572060 | PMS-METHADONE TABLETS | PHARMASCIENCE INC | 5 MG | Tablet | Approved |
| 02572079 | PMS-METHADONE TABLETS | PHARMASCIENCE INC | 10 MG | Tablet | Approved |
| 02572087 | PMS-METHADONE TABLETS | PHARMASCIENCE INC | 25 MG | Tablet | Approved |
Sourcing Methadone Hydrochloride through a licensed wholesaler
Nexara Health imports and distributes under Health Canada Drug Establishment Licence #3-002896. For Methadone Hydrochloride we can quote Canadian-marketed presentations, equivalent registrations from the EU, UK, US, Switzerland, Australia, and Japan where the Canadian presentation is unavailable, and comparator-grade supply with Certificate of Analysis, batch and expiry records, and full chain of custody for clinical trial use. Cold-chain presentations ship under GDP conditions with continuous temperature monitoring.
Request a quote
Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for Methadone Hydrochloride and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.
Request a sourcing quote or call +1 (431) 588-9055.